Human Papillomavirus Type 16 Early Protein E7 Activates Autophagy through Inhibition of Dual-Specificity Phosphatase 5

Abstract

Consistent high-risk human papillomavirus (HPV) infection leads to various malignant cancers. Autophagy can promote cancer progression by helping cancer cells survive under stress or induce oncogenic effects when mutations or abnormalities occur. Mitogen activated protein kinases (MAPKs) can transduce various external or intrinsic stimuli into cellular responses, including autophagy, and dual-specificity phosphates (DUSPs) contribute to the direct regulation of MAPK activities. Previously, we showed that expression of DUSP5 was repressed in HPV16 E7-expressing normal human epidermal keratinocytes (NHEKs). Here we show that clinical HPV16 E7-positive precancerous and cancerous tissues also demonstrate low DUSP5 levels compared with control tissues, indicating that the inverse correlation between HPV16 E7 and DUSP5 is clinically relevant. We furthermore investigated the autophagy response in both DUSP5-deficient and HPV16 E7-expressing NHEKs. Confocal microscopy and Western analysis showed induction of LC3-II levels, autophagosome formation and autophagy fluxes in DUSP5-deficient NHEKs. Furthermore, Western analysis demonstrated specific induction of phosphorylated ERK in DUSP5-deficient and HPV16 E7-expressing NHEKs, indicating that HPV16 E7-mediated repression of DUSP5 results in induced MAPK/ERK signaling. Finally, phosphorylated mTOR and ULK (S757) were reduced in DUSP5-deficient NHEKs, while phosphorylated ULK (S555) and AMPK were increased, thereby inducing canonical autophagy through the mTOR and AMPK pathways. In conclusion, our results demonstrate that HPV16 E7 expression reduces DUSP5 levels, which in turn results in active MAPK/ERK signaling and induction of canonical autophagy through mTOR and MAPK regulation. Given its demonstrated inverse correlation with clinical cancerous tissues, DUSP5 may serve as a potential therapeutic target for cervical cancer.

Cellular communication network factor 1 interlinks autophagy and ERK signaling to promote osteogenesis of periodontal ligament stem cells

“…On one hand, phosphorylation of ERK can inhibit mTOR, thereby promoting autophagy. Increased pERK1/2 downregulates the phosphorylation level of p70S6K, one of the mTORC1 substrates, thereby inhibiting mTORC1 activation 42,43 . On the other hand, AMPK can directly or indirectly activate ULK1, which is an important upstream pathway for autophagy activation 44,45 .…”

“…Increased pERK1/2 downregulates the phosphorylation level of p70S6K, one of the mTORC1 substrates, thereby inhibiting mTORC1 activation. 42,43 On the other hand, AMPK can directly or indirectly activate ULK1, which is an important upstream pathway for autophagy activation. 44,45 Activated MEK/ERK1/2 can positively regulate AMPK and promote the phosphorylation of AMPKα.…”

Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model

“…Skin, spleen, and lymph node tissues were harvested on day 30 and fixed in formalin before embedding in paraffin. The procedures of deparaffinization, rehydration, antigen retrieval, and blocking were described previously [ 33 ]. Primary antibodies used for immunohistochemistry staining were Ki67 (#12202s, CST), CD4 (#25229S, CST), CD8 (#98941S, CST), CD1a (#17325-1-AP, Proteintech), CXCR3 (#26756-1-AP, Proteintech), CCR3 (#bs-1167R, Bioss).…”

Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions

“…Additionally, HPV11 E6 was found to repress AKT/mTOR and Erk/mTOR, culminating in autophagy activation 177 . HPV16 E7 can also triggers autography by inhibiting dual‐specificity phosphatase 5 178 . The expression of HPV oncoproteins can activate autophagy through different pathways, which fosters the survival of HPV‐infected cells.…”